Broncus Holding (HKG:2216) received marketing approval from the Zhejiang Medical Products Administration for its lung imaging processing software, BroncQCT, according to a Friday filing with the Hong Kong bourse.
The software enables lung CT scans through advanced algorithms, offering 3D reconstructions and quantitative data for diagnosis and treatment planning.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.